Twist Bioscience Corporation
NASDAQ:TWST
42.75 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 312.974 | 245.109 | 203.565 | 132.333 | 90.1 | 54.385 | 25.427 | 10.767 | 2.269 |
| Cost of Revenue
| 179.625 | 155.38 | 119.33 | 80.62 | 61.406 | 47.426 | 32.189 | 24.02 | 9.421 |
| Gross Profit
| 133.349 | 89.729 | 84.235 | 51.713 | 28.694 | 6.959 | -6.762 | -13.253 | -7.152 |
| Gross Profit Ratio
| 0.426 | 0.366 | 0.414 | 0.391 | 0.318 | 0.128 | -0.266 | -1.231 | -3.152 |
| Reseach & Development Expenses
| 90.852 | 106.894 | 120.307 | 69.072 | 43.006 | 35.683 | 20.347 | 19.169 | 18.23 |
| General & Administrative Expenses
| 0 | 186.838 | 210.549 | 133.401 | 102.067 | 78.826 | 42.55 | 25.96 | 18.074 |
| Selling & Marketing Expenses
| 0 | 2.9 | 2.4 | 2.5 | 1.2 | 1.3 | 0.9 | 0.1 | 0.2 |
| SG&A
| 218.398 | 189.738 | 212.949 | 135.901 | 103.267 | 80.126 | 43.45 | 26.06 | 18.274 |
| Other Expenses
| 44.93 | 10.256 | -1.087 | -1.37 | -0.182 | -0.265 | -0.121 | -0.055 | 0.073 |
| Operating Expenses
| 354.18 | 306.888 | 333.256 | 204.973 | 146.273 | 115.809 | 63.797 | 45.229 | 36.504 |
| Operating Income
| -220.831 | -217.159 | -249.021 | -153.26 | -117.579 | -108.85 | -70.559 | -58.482 | -43.656 |
| Operating Income Ratio
| -0.706 | -0.886 | -1.223 | -1.158 | -1.305 | -2.001 | -2.775 | -5.432 | -19.24 |
| Total Other Income Expenses Net
| 12.665 | 13.693 | 6.502 | -1.302 | 0.53 | 1.473 | -0.435 | -0.548 | -0.432 |
| Income Before Tax
| -208.166 | -203.466 | -228.274 | -154.028 | -139.549 | -107.377 | -70.994 | -59.03 | -44.088 |
| Income Before Tax Ratio
| -0.665 | -0.83 | -1.121 | -1.164 | -1.549 | -1.974 | -2.792 | -5.482 | -19.431 |
| Income Tax Expense
| 0.56 | 1.152 | -10.411 | -1.93 | 0.382 | 0.292 | 0.242 | 0.28 | 0.819 |
| Net Income
| -208.726 | -204.618 | -217.863 | -152.098 | -139.931 | -107.669 | -71.236 | -59.31 | -44.088 |
| Net Income Ratio
| -0.667 | -0.835 | -1.07 | -1.149 | -1.553 | -1.98 | -2.802 | -5.508 | -19.431 |
| EPS
| -3.6 | -3.6 | -4.04 | -3.15 | -3.57 | -3.92 | -2.68 | -3.16 | -2.35 |
| EPS Diluted
| -3.6 | -3.6 | -4.04 | -3.15 | -3.57 | -3.92 | -2.68 | -3.16 | -2.35 |
| EBITDA
| -176.705 | -174.151 | -191.553 | -143.911 | -132.085 | -99.772 | -63.954 | -53.104 | -39.113 |
| EBITDA Ratio
| -0.565 | -0.711 | -1.214 | -1.165 | -1.29 | -1.951 | -2.515 | -4.932 | -17.238 |